Pay in 4 interest-free payments of $5.74 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
2019;7:e617
The auto-injector pen might deliver the medication slightly differently into the subcutaneous tissue than a traditional syringe
Social divides persist: 73% of women and 61% of men feel pressure to lose weight
Tirzepatide is FDA-approved for: Individuals with a body mass index of 30 (or 27 with weight-related conditions such as, type 2 diabetes mellitus, or metabolic resistance) Women managing Polycystic Ovary Syndrome (PCOS) Those with prediabetes or insulin resistance Anyone whos struggled with weight despite consistent efforts and is ready for a more targeted, science-backed solution If youre unsure whether you qualify, a simple consultation with a qualified provider can help determine if Tirzepatide aligns with your health goals
US$ 28.96
US$ 20.34
US$ 29.04
US$ 26.54
